Compounded products must instead meet applicable 503A (patient-specific) or 503B (outsourcing facility) requirements and should be prescribed based on individualized clinical need
Researchers investigate Big picture view: In the study, researchers at the University of Virginia specifically investigated small-molecule GLP-1 receptor agonists, such as the Food and Drug Administration (FDA)-approved orforglipron, which can be taken orally and are cheaper to produce than their injectable counterparts
Where is the compounded medication sourced
These medications are covered based on medical necessity and require prior authorization from the members physician
Redox Biol 51:102262 Ramakrishnan M, Arivalagan J, Satish L, Mohan M, Samuel SCJ, Chandran SA, Ju HJ, John LA, Ramesh T, Ignacimuthu S, Kalishwaralal K (2022) Selenium: a potent regulator of ferroptosis and biomass production